For much of the past decade, the psychedelic renaissance has revolved around experience. Carefully supervised psilocybin sessions. Structured integration. Regulatory pathways built around high-touch therapeutic models. But beneath that narrative, a deeper scientific shift has been taking shape. The real engine of change may not be the subjective trip at all, but the intracellular signaling that reshapes neural circuits.
